PHARMACY

Immunization nation: Pharmacists flex their clinical muscles, build revenue
Pharmacists have made substantial headway as immunizers, even overcoming pushback from many physicians who viewed pharmacists as a threat to their revenue stream to become a trusted resource and accessible source for patients’ vaccination needs.
NACDS applauds Kansas’ e-prescribing law to prevent opioid abuse
Sixty-two percent of Kansas voters support an e-prescribing requirement as an opioid fraud and abuse prevention strategy.

Camber receives HDA recognition

Camber received HDA's award for Second Merit Finalist for Best Overall Generic Pharmaceutical Product Manufacturer with Less Than $100 Million in Sales to Healthcare Distributors.
McKesson kicks off ideaShare 2019

Health Mart is offering education and new tools at ideaShare 2019 meant to spur the growth of its independent pharmacies.
Alembic gets FDA nod for generic Bromday

Bromfenac ophthalmic solution 0.09% has a market value of $6 million for the 12 months ending December 2018, according to IQVIA.
Dr. Reddy’s launches generic Tobi

Tobi (tobramycin) inhalation solution brand and generic had a market value of approximately $97 million for the most recent 12 months ended April 2019.
AbbVie to acquire Allergan in $63B deal

The combined company will consist of several franchises with leadership positions across immunology, hematologic oncology, medical aesthetics, neuroscience, women's health, eye care and virology, the companies said.
Rising Pharmaceuticals debuts generic Canasa

Mesalamine suppositories had a market value of roughly $263 million for the 12 months ended March 2019, according to IQVIA.
Schnucks to host free concert to support Folds of Honor

Schnuck Markets' free concert, featuring John Rich, benefits the Folds of Honor Foundation, which recognizes fallen and disabled military veterans by providing educational scholarships to their spouses and children.
Dr. Reddy’s launches generic vitamin K1

The vitamin K1 (phytonadione) injectable emulsion 10 mg/ml had a brand and generic market value of roughly $46.6 million for the 12 months ended April 2019.